Intellectual Property India Publishes Patent Application for 'Nucleic Acids Encoding Tgf-Beta Inhibitor And Il-12 And Uses Thereof' Filed by Kalivir Immunotherapeutics, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517036506 A) filed by Kalivir Immunotherapeutics, Inc., Pittsburgh, on April 15, for 'nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof.'

Inventor(s) include Thorne, Stephen Howard; and Zhang, Mingrui.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides for a nucleic acids encoding for a transforming growth factor inhibitor and IL-12. Further provided herein are nucleic acids encoding for chemokine receptor CXCR3. Additionally described herein are oncolytic viruses comprising the nucleic acids desc...